In Seddighi et al., our groups first demonstrated the presence of de novo cryptic peptides in iPSC-derived neurons with TDP-43 knockdown, and then used a novel targeted proteomics assay to confirm the presence of cryptic peptides in CSF of patients with ALS-FTD [58]. Here, TARDBP is linked to frontotemporal dementia.